Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium dobesilate for diabetic nephropathy with albuminuria
ChiCTR-IPR-17013639Phase 4Recruiting
- Sponsor
- Zhu Xianyi Memorial Hospital
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of calcium dobesilate in diabetic glomerulosclerosis (2 arms), sponsored by Zhu Xianyi Memorial Hospital. Primary endpoints: Urinary albumin creatinine ratio and miRNA expression. Started Dec 2017; status: recruiting.
02
Drugs
calcium dobesilate
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR-IPR-17013639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013639.